Gilead Sciences, INC. (GILD) — 8-K Filings

All 8-K filings from Gilead Sciences, INC.. Browse 19 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (19)

8-K Filing — Nov 19, 2025
Gilead Sciences Files 8-K on Financials — Oct 30, 2025 Risk: low
Gilead Sciences, Inc. filed an 8-K on October 30, 2025, reporting on its results of operations and financial condition. The filing includes financial statements
Gilead Sciences Files 8-K Report — Oct 6, 2025 Risk: low
On October 6, 2025, Gilead Sciences, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements and exhibits. No
Gilead Sciences 8-K: Officer & Director Changes — Aug 14, 2025 Risk: low
Gilead Sciences, Inc. filed an 8-K on August 14, 2025, reporting events as of August 10, 2025. The filing covers the departure of directors or certain officers,
Gilead Sciences Files 8-K: Bylaws & Financials — Aug 4, 2025 Risk: low
Gilead Sciences, Inc. filed an 8-K on July 30, 2025, reporting amendments to its articles of incorporation or bylaws and filing financial statements and exhibit
Gilead Sciences Files 8-K on Shareholder Votes and Exhibits — May 8, 2025 Risk: low
Gilead Sciences, Inc. filed an 8-K on May 8, 2025, reporting on matters submitted to a vote of security holders and financial statements/exhibits as of May 7, 2
Gilead Sciences Files 8-K on Financials — Apr 24, 2025 Risk: low
On April 24, 2025, Gilead Sciences, Inc. filed an 8-K report. The filing indicates that the report is primarily related to Results of Operations and Financial C
Gilead Sciences Announces Executive and Board Changes — Mar 12, 2025 Risk: medium
Gilead Sciences, Inc. announced on March 9, 2025, changes in its executive team and board of directors. The filing details the departure of certain officers and
Gilead Sciences Files 8-K on Financials — Feb 11, 2025 Risk: low
On February 11, 2025, Gilead Sciences, Inc. filed an 8-K report to disclose information regarding its results of operations and financial condition. The filing
Gilead Sciences Enters Material Agreement, Creates Financial Obligation — Nov 20, 2024 Risk: medium
On November 20, 2024, Gilead Sciences, Inc. entered into a material definitive agreement, likely related to financing or a significant transaction. This filing
Gilead Sciences Files 8-K on Financials — Nov 6, 2024 Risk: low
On November 6, 2024, Gilead Sciences, Inc. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements
Gilead Sciences Announces Board and Executive Compensation Changes — Jul 17, 2024 Risk: low
Gilead Sciences, Inc. announced on July 17, 2024, changes in its board of directors and executive compensation. The filing details the departure of certain dire
Gilead Sciences Holds Annual Meeting, Elects Directors — May 9, 2024 Risk: low
On May 8, 2024, Gilead Sciences, Inc. filed an 8-K report detailing several key events. The company announced the results of its annual meeting of stockholders,
Gilead Sciences Files 8-K on Financials — Apr 25, 2024 Risk: low
Gilead Sciences, Inc. filed an 8-K on April 25, 2024, reporting on its results of operations and financial condition, as well as filing financial statements and
Gilead Sciences Files 8-K Report — Mar 22, 2024 Risk: low
On March 22, 2024, Gilead Sciences, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Reg
Gilead Sciences Announces Executive and Board Changes — Mar 14, 2024 Risk: low
Gilead Sciences, Inc. announced on March 10, 2024, changes in its executive leadership and board of directors. The company elected two new directors, Dr. Debora
Gilead Files 8-K on Material Definitive Agreement, Other Events — Feb 12, 2024 Risk: medium
Gilead Sciences, Inc. filed an 8-K on February 12, 2024, reporting an "Entry into a Material Definitive Agreement" and "Other Events" that occurred on February
Gilead Files 8-K on Financial Results & Condition — Feb 6, 2024
Gilead Sciences, Inc. filed an 8-K on February 6, 2024, to report its financial results and condition, as well as to include related exhibits. This filing, unde
Gilead Reports Officer Comp/Director Changes on Feb 1 — Feb 2, 2024
Gilead Sciences, Inc. filed an 8-K on February 2, 2024, reporting an event that occurred on February 1, 2024. This filing indicates a change in compensatory arr

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX